Cobamides, a uniquely diverse family of enzyme cofactors related to vitamin B 12 , are produced exclusively by bacteria and archaea but used in all domains of life. While it is widely accepted that cobamide-dependent organisms require specific cobamides for their metabolism, the biochemical mechanisms that make cobamides functionally distinct are largely unknown. Here, we examine the effects of cobamide structural variation on a model cobamide-dependent enzyme, methylmalonyl-CoA mutase (MCM). The in vitro binding affinity of MCM for cobamides can be dramatically influenced by small changes in the structure of the lower ligand of the cobamide, and binding selectivity differs between bacterial orthologs of MCM. In contrast, variations in the lower ligand have minor effects on MCM catalysis. Bacterial growth assays demonstrate that cobamide requirements of MCM in vitro largely correlate with in vivo cobamide dependence. This result underscores the importance of enzyme selectivity in the cobamidedependent physiology of bacteria.
Introduction
Cobalamin, commonly referred to as vitamin B 12 , is a versatile enzyme cofactor used by organisms in all domains of life. In humans, cobalamin is essential for methionine synthesis and the breakdown of fatty acids, amino acids, and cholesterol (Brodie et al., 1970; Fenton et al., 1982) . Bacteria and archaea additionally use cobalamin and related cofactors, cobamides, for deoxyribonucleotide synthesis (Licht et al., 1996) , metabolism of various carbon and energy sources (Barker, 1985; Berg et al., 2007; Chang and Frey, 2000; Chen et al., 2001; Erb et al., 2008; Ferguson and Krzycki, 1997; Forage and Foster, 1982; Jeter, 1990; Korotkova et al., 2002; Krasotkina et al., 2001; Ljungdahl, 1986; Scarlett and Turner, 1976; Stupperich and Konle, 1993; Vrijbloed et al., 1999) , synthesis of secondary metabolites (Allen and Wang, 2014; Blaszczyk et al., 2016; Jung et al., 2014; Kim et al., 2017; Marous et al., 2015; Pierre et al., 2012; Werner et al., 2011) , sensing light (Ortiz-Guerrero et al., 2011) , and other processes (Barker, 1985; Chang and Frey, 2000; Chen et al., 2001; Cracan and Banerjee, 2012; Gough et al., 2000; Miles et al., 2011; Parks et al., 2013; Romine et al., 2017; Yaneva et al., 2012) . The finding that 86% of bacterial species encode at least one cobamidedependent enzyme in their genome (Shelton et al., 2019) demonstrates the prevalence of cobamide-dependent metabolisms. Widespread use of these cofactors can be attributed to their chemical versatility, as they facilitate challenging chemical reactions including radical-initiated rearrangements, methylation reactions, and reductive cleavage of chemical bonds (Banerjee and Ragsdale, 2003; .
All cobamides share the same core structure ( Figure 1 ): a corrin ring that coordinates a cobalt ion, a variable "upper" axial ligand (R in Figure 1 ), and a pseudo-nucleotide that is covalently attached to the corrin ring through an aminopropanol linker (Hodgkin et al., 1956) or an ethanolamine linker, in the case of nor-cobamides (Keller et al., 2016; Kräutler et al., 2003) . The major differences among cobamides are in the structure of the nucleotide base, more commonly referred to as the lower axial ligand for its ability to coordinate the central cobalt ion. In cobalamin, the lower ligand is 5,6-dimethylbenzimidazole ( Figure 1 , boxed); in other cobamides, different benzimidazoles, phenolics, and purines constitute the lower ligand ( Figure  2D ) (Allen and Stabler, 2008; Girard et al., 2009; Men et al., 2015; Renz, 1999; Yan et al., 2018) .
While cobamides containing different lower ligands share the same chemically reactive moieties, specifically the cobalt center and methyl or 5'-deoxyadenosyl upper axial ligands, they are nonetheless functionally distinct. Culture-based studies have shown that only a subset of cobamides supports a given bacterial metabolism, and uptake or production of other cobamides can inhibit growth (Helliwell et al., 2016; Keller et al., 2018; Mok and Taga, 2013; Watanabe et al., 1992; Yan et al., 2018; Yan et al., 2016; Yi et al., 2012) . The requirements of bacteria for particular cobamides is notable given the diversity of cobamides present in host-associated and environmental samples (Allen and Stabler, 2008; Girard et al., 2009; Men et al., 2015) , coupled with the absence of de novo cobamide biosynthesis in more than half of bacteria (Shelton et al., 2019) . Despite the biological relevance of cobamide structure, and the prevalence of cobamide use among bacteria (Degnan et al., 2014a; Rodionov et al., 2003; Shelton et al., 2019; Zhang et al., 2009) , little is understood about the biochemical mechanisms by which cobamides differentially impact microbial physiology.
The effect of lower ligand structure on the biochemistry of cobamide-dependent enzymes has been studied to a limited extent. In "base-on" enzymes, the lower ligand base coordinates the central cobalt ion of the cobamide, as drawn in Figure 1 (Larsson et al., 2010; Shibata et al., 2018; Yamanishi et al., 2002) . Because the lower ligand is part of the catalytic center of the enzyme, lower ligand structure can influence catalysis through a variety of mechanisms (Brown, 2006; Conrad et al., 2015; Kozlowski and Zgierski, 2004) , and cobamides unable to form an intramolecular coordinate bond are catalytically inactive in base-on enzymes (Poppe et al., 2000; Poppe et al., 1997) . In contrast, in "base-off" enzymes the lower ligand is bound by the enzyme more than 10 Å away from the active site (Berkovitch et al., 2004; Bommer et al., 2014; Drennan et al., 1994; Gruber et al., 2001; Jost et al., 2015; Kurteva-Yaneva et al., 2015; Mancia et al., 1996; Payne et al., 2015a; Payne et al., 2015b; Wolthers et al., 2010) . In a subset of base-off enzymes, referred to as "base-off/His-on," a histidine residue from the protein coordinates the cobalt ion in place of the lower ligand (Drennan et al., 1994; Mancia et al., 1996) . Despite its distance from the reactive center, lower ligand structure affects the activity of base-off enzymes, as evidenced by the cobamide cofactor selectivity of methionine synthase , methylmalonyl-CoA mutase (MCM) (Lengyel et al., 1960; Poppe et al., 1997) , reductive dehalogenases (Keller et al., 2018) , and other enzymes (Barker et al., 1960; Lengyel et al., 1960; Poppe et al., 2000) . However, the mechanisms by which lower ligand structure affects the biochemistry of base-off cobamidedependent enzymes remain unclear.
As MCM is one of the most abundant cobamide-dependent enzymes in bacterial genomes (Shelton et al., 2019) , and one of the two cobamide-dependent enzymes in humans, we have chosen to study the cobamide selectivity of MCM as a model for base-off/His-on enzymes, all of which share a structurally conserved B 12 -binding domain (Dowling et al., 2012; Drennan et al., 1994) . MCM catalyzes the interconversion of (R)-methylmalonyl-CoA and succinyl-CoA, a bidirectional reaction used in propionate metabolism (Hosotani et al., 1980; Savvi et al., 2008; Vrijbloed et al., 1999) , catabolism of branched amino acids and odd-chain fatty acids (Fenton et al., 2014; Savvi et al., 2008) , polyhydroxybutyrate degradation (Charles et al., 1997) , secondary metabolite biosynthesis (Hunaiti and Kolattukudy, 1984) , and autotrophic carbon dioxide fixation (Berg et al., 2007; Han et al., 2012) . MCM-dependent pathways have been harnessed industrially for the bioproduction of propionate, bioplastics, biofuels, and antibiotics (Akawi et al., 2015; Aldor et al., 2002; Dayem et al., 2002; Gonzalez-Garcia et al., 2017; Gross et al., 2006; Li et al., 2017; Reeves et al., 2007; Srirangan et al., 2013) .
The presence of a cobamide lower ligand is required for MCM activity, as evidenced by the observation that adenosylcobinamide, a cobamide intermediate lacking a lower ligand (Figure 1 ), does not support MCM activity in vitro (Chowdhury and Banerjee, 1999 (Lengyel et al., 1960) . Second, P. shermanii MCM had a lower apparent K M for Ado[Cre]Cba than AdoCbl (Poppe et al., 1997) (De Hertogh et al., 1964) . Each of these studies includes only one or two cobamides other than cobalamin, and understandably so; cobamides are difficult to obtain in high quantities and must be purified from large volumes of bacterial cultures. Because of this, the response of MCM orthologs to the full diversity of cobamides has not been explored, and the mechanistic basis of cobamide selectivity remains unclear.
To investigate the mechanisms by which diverse lower ligands affect MCM function, we conducted in vitro binding and activity assays with MCM from S. meliloti (SmMCM). We discovered major differences in the binding affinities of eight naturally occurring cobamides for SmMCM, while cobamide structure affected enzyme activity to a lesser extent. Using six additional cobamides, five of which are novel analogs that have not been observed in nature or described previously, we identified structural elements of lower ligands that are determinants of binding to SmMCM. To probe the hypothesis that enzyme selectivity influences bacterial growth, we characterized the cobamide dependence of S. meliloti growth in vivo. By bridging the results of in vitro biochemistry of three bacterial MCM orthologs and the cobamide-dependent growth phenotypes of S. meliloti, we have elucidated molecular factors that contribute to the cobamidedependent physiology of bacteria.
Results
Lower ligand structure influences cobamide binding to MCM.
We chose SmMCM as a model to examine how lower ligand structure influences MCM function based on previous work demonstrating its activity as a homodimer encoded by a single gene (Charles and Aneja, 1999; Miyamoto et al., 2003) . We purified eight naturally occurring cobamides for in vitro studies of this protein, and chemically adenosylated each cobamide to produce the biologically active form used by MCM for catalysis. Previous studies showed that binding of cobamides to P. shermanii MCM can be detected in vitro by measuring quenching of intrinsic protein fluorescence (Chowdhury and Banerjee, 1999) . We found that the fluorescence of purified, His-tagged SmMCM also decreased in a dose-dependent manner when the protein was reconstituted with increasing concentrations of AdoCbl (Figure 2A ). The equilibrium dissociation constant (K d ) derived from these measurements, 0.03 ± 0.02 µM ( Figure 2D ), is 6-fold lower than the K d reported for P. shermanii MCM (Chowdhury and Banerjee, 1999) . Adocobinamide also bound SmMCM, as was observed with P. shermanii MCM (Chowdhury and Banerjee, 1999) , albeit with over 10-fold reduced affinity compared to cobalamin (Figure 2A, D) .
We next measured binding of other benzimidazolyl cobamides to SmMCM and found that Ado[5-MeBza]Cba and Ado[Bza]Cba, the cobamides most structurally similar to AdoCbl, also bound the enzyme. However, the absence of one or two methyl groups, respectively, in the lower ligands of these cobamides caused a decrease in binding affinity relative to AdoCbl (Figure 2A, D Figure S1A, B) .
We expanded our analysis of SmMCM-cobamide binding selectivity to include cobamides from other structural classes. Both of the phenolyl cobamides tested, Ado Figure S1C ). Interestingly, for all three classes of lower ligands, the presence of a methyl substituent promoted binding relative to other cobamides of the same structural class.
Identification of structural elements that interfere with cobamide binding.
When cobamides are bound to MCM, the lower ligand is surrounded by protein residues (Froese et al., 2010; Mancia et al., 1996) . Therefore, the reduced affinity of certain cobamides for the enzyme could be a result of exclusion of their lower ligands from this binding pocket because of steric or electrostatic repulsion. We hypothesized that the poor binding of the purinyl cobamides Ado[Ade]Cba and Ado[2-MeAde]Cba is due to the presence of the exocylic amine (N10) based on several observations: 1) Ado[5-OHBza]Cba, which also contains a polar functional group, had impaired binding ( Figure 2A, D) ; 2) in a crystal structure of Homo sapiens MCM (HsMCM) (Froese et al., 2010) , residues Ala731, Thr726, and Phe721, all of which are conserved in SmMCM, would be expected to sterically interfere with the binding of an exocyclic amine ( Figure S2A , asterisk); and 3) structural modeling of HsMCM, which shares 59% amino acid identity to SmMCM in the B 12 -binding domain, bound to Ado[Ade]Cba suggests a significant displacement of the adenine lower ligand relative to the position of the lower ligand of AdoCbl, accompanied by significant expansion of the lower ligand binding pocket, which would be an unlikely conformation for the protein to adopt .
To test the importance of the exocyclic amine of adenine in cofactor exclusion, we produced an unsubstituted purinyl cobamide, Ado[Pur]Cba (Yan et al., 2018) . Ado[Pur]Cba also had low affinity for SmMCM ( Figure To test whether cofactor-binding selectivity is a general phenomenon across bacterial MCM orthologs, we compared the cobamide-binding profile of SmMCM to that of MCM orthologs from Escherichia coli (EcMCM) and Veillonella parvula (VpMCM). Activity of EcMCM with AdoCbl has been reported both in vivo and in vitro, although its physiological role in E. coli remains unclear (Gonzalez-Garcia et al., 2017; Haller et al., 2000) . Annotations for two MCM homologs are present in the genome of V. parvula, and we purified the one that exhibits MCM activity when expressed in S. meliloti (see Materials and Methods). Because S. meliloti produces cobalamin (Kliewer and Evans, 1963) , E. coli produces [2-MeAde]Cba when provided cobinamide (Hazra et al., 2015) , and V. parvula produces [Cre]Cba , we expected that each ortholog should have distinct cobamide selectivity. As expected, EcMCM had highest affinity for its native cobamide, Ado We constructed a sequence alignment of MCM orthologs from diverse organisms known to produce or use various cobamides, in search of amino acid residues that could account for differences in cobamide binding ( Figure S3A ). The B 12 -binding domains of diverse MCM orthologs had high overall amino acid identity (38-70%). Cases of low identity correlated with differences in the structural configuration of MCM, which occurs in different organisms as a homodimer (Froese et al., 2010; Haller et al., 2000; Miyamoto et al., 2010; Miyamoto et al., 2003) , heterodimer (Birch et al., 1993; Mancia et al., 1996; Miyamoto et al., 2002; Zhang et al., 1999) , or heterotetramer (Han et al., 2012; Yabuta et al., 2015) ( Figure S3B ). We focused our analysis on residues immediately surrounding the lower ligand in the structure of HsMCM ( Figure 3A , triangles). For the most part, these residues are highly conserved between orthologs. Interestingly, however, HsMCM residues Phe638, Phe722, and Ala731, which are conserved in SmMCM, are substituted with the more polar residues Tyr, Tyr, and Ser, respectively, in EcMCM ( Figure S3A ), which has a higher affinity for purinyl cobamides. Whether or not these residues co-vary with cobamide selectivity across other MCM orthologs is difficult to interpret because the cobamide selectivity of MCM from most organisms is unknown.
The lower ligand of cobamides modulates MCM reaction kinetics.
We reconstituted SmMCM with saturating amounts of the five cobamides that bound with highest affinity and measured conversion of (R)-methylmalonyl-CoA to succinyl-CoA under steady state conditions. Interestingly, the substrate K M was nearly invariable among the cobamides tested (Figure 4) . Turnover was highest with AdoCbl (26 ± 1 s -1 ) and 2-to 3-fold lower with other cobamides. Thus, all of the cobamides tested, including the unnatural cobamide analogs, supported SmMCM catalysis with modest differences in k cat . This finding is consistent with a previous observation that adenosylcobinamide-GDP, a cobamide precursor with an extended nucleotide loop and a guanine base, supported activity of P. shermanii MCM with only slight catalytic impairment compared to AdoCbl (Chowdhury et al., 2001 ).
MCM-dependent growth of S. meliloti correlates with the binding selectivity of SmMCM for benzimidazolyl and purinyl cobamides, but not phenolyl cobamides.
To assess whether the cobamide-dependent growth of S. meliloti reflects MCM selectivity as observed in vitro, we cultured S. meliloti under conditions that require MCM activity. Examination of metabolic pathways encoded in the S. meliloti genome using the KEGG database (Kanehisa and Goto, 2000) suggests that the degradation of branched amino acids isoleucine and valine to succinyl-CoA, an intermediate of the citric acid cycle, requires MCM. Indeed, growth of S. meliloti on L-isoleucine and L-valine as the only carbon sources was dependent on the presence of the bhbA gene, which encodes MCM (Charles and Aneja, 1999) ( Figure S4 ).
We constructed an S. meliloti strain incapable of synthesizing cobalamin and lacking cobamide-dependent enzymes other than MCM to ensure that differential growth could be attributed solely to MCM selectivity for added cobamides (see Materials and Methods). We cultivated this strain with L-isoleucine and L-valine as sole carbon sources in medium supplemented with different cobamides in their cyanylated (CN) forms, which is the form typically used for in vivo growth assays. Under these growth conditions, the maximum growth yield (OD 600 ) achieved at high concentrations of all of the cobamides was indistinguishable ( Figure S5 ). However, the concentration of cobamides required to achieve half of the maximal OD 600 (EC 50 ) differed based on the cobamide provided (Figure 5 [Pur] Cba to support growth suggests that these cobamides can bind SmMCM at concentrations higher than those tested in vitro; a control experiment with an S. meliloti strain lacking MCM rules out the possibility that high concentrations of cobamides (10 µM) abiotically enable growth on isoleucine and valine ( Figure S4) .
We considered the possibility that differences in cobamide internalization by S. meliloti could also influence the EC 50 measurements shown in Figure 
Discussion
Cobamides are distinct from other cofactors in their extensive structural diversity, with over a dozen forms that differ in the lower ligand base and nucleotide loop. How cobamide lower ligand structure influences the activity of cobamide-dependent enzymes has not been extensively explored. Here, we report a systematic analysis of the effects of cobamide lower ligand structure on the function of a model cobamide-dependent enzyme, MCM. Our results show that MCM exhibits varied affinities for different cobamides, and that this selectivity is linked to the physiology of the organism.
Our results show that the major determinant of cobamide selectivity in SmMCM is binding, with small changes in the lower ligand capable of dramatically altering the binding affinity of a cobamide. One explanation for these differences is that the chemical compatibility between the lower ligand base and the binding pocket of the protein strongly influences the binding affinity of cobamides; repulsion of the lower ligand on the basis of electrostatics could reduce the binding affinity of cobamides to MCM. While the structure of SmMCM has not been determined, a model generated by sequence alignment to HsMCM suggested a highly hydrophobic lower ligand binding pocket. Consistent with this, we observed higher affinity of cobamides with hydrophobic lower ligands to SmMCM, as well as interference of ring nitrogens with cobamide binding. Introducing mutations to change the properties of the lower ligand binding pocket of SmMCM to accommodate alternative lower ligands proved challenging, as it resulted in reduced protein solubility and overall impaired cobamide binding (data not shown).
On the other hand, sequence alignments suggested that many of the hydrophobic residues predicted to immediately surround the lower ligand are conserved between diverse MCM orthologs that differ in cobamide selectivity. Assuming that the arrangement of the lower ligand binding pocket is similar across MCM orthologs, this suggests that interactions within the lower ligand binding pocket are not sufficient to account for selectivity. In a similar vein, examination of the residues surrounding the lower ligand in the cobamide-bound structures of reductive dehalogenases does not reveal the basis of exclusion of certain cobamides (Keller et al., 2018) . These observations suggest that the lower ligand may have an unknown role in the binding of cobamides to MCM. Consistent with this idea, studies of the kinetics and pH dependence of AdoCbl binding to P. shermanii MCM suggest a pre-association step, wherein a cofactor-protein complex is formed prior to displacement of the lower ligand of the cofactor by a histidine residue in the protein (Chowdhury and Banerjee, 1999) . The nature of this complex is unknown, but potential interactions between the lower ligand and this conformation of the enzyme could provide an opportunity for lower ligand structure to impact the outcome of binding.
Our analysis of MCM orthologs from E. coli and V. parvula demonstrates that variations in cobamide selectivity have evolved in organisms with different physiologies. The cobamide selectivity patterns in the three MCM orthologs we examined correlate with the physiologies of the bacteria in two ways. First, in all three cases, each MCM ortholog has highest affinity for the native cobamide produced by the organism, suggesting that cobamide biosynthesis and selectivity of cobamide-dependent enzymes have coevolved. Second, SmMCM is more selective than EcMCM and VpMCM, and these differences in selectivity correlate with differences in cobamide biosynthesis, acquisition, and use in these organisms. S. meliloti synthesizes cobalamin de novo and is incapable of attaching purinyl and phenolyl lower ligands to cobamide precursors . Thus, its cobamide-dependent enzymes have likely evolved to function best with cobalamin. In contrast, E. coli does not synthesize cobamides de novo and instead relies on the importer BtuBFCD to acquire cobamides from the environment (Borths et al., 2005; Heller et al., 1985) . Alternatively, E. coli can produce a variety of benzimidazolyl and purinyl cobamides when provided with precursors (Hazra et al., 2015) , making the ability to use multiple cobamides likely advantageous. Like S. meliloti, V. parvula synthesizes cobamides de novo, but can produce both benzimidazolyl and phenolyl cobamides Hazra et al., 2013) and also encodes membrane transport components adjacent to cobalamin riboswitches (Mukherjee et al., 2019) , which are likely to be cobamide importers (Nahvi et al., 2004; Rodionov et al., 2003) . Thus, the ability of VpMCM to bind diverse cobamides is similarly consistent with its physiology.
Relative to cobamide binding selectivity, our results suggest that effects of lower ligand structure on the catalytic activity of MCM are minor. Among the cobamides we tested, the maximum differences in SmMCM turnover were 3-fold. We did not observe inhibition of MCM activity with any cobamides, in contrast to the strong inhibition that has been observed with analogs containing variations in the upper ligand or central metal, known as antivitamins (Calafat et al., 1995; Fukuoka et al., 2005; Widner et al., 2016) .
In addition to elucidating the biochemical basis of cobamide selectivity in MCM, a major aim of our work was to link biochemical selectivity with cobamide-dependent growth. Our results with benzimidazolyl and purinyl cobamides support the hypothesis that enzyme selectivity is a major determinant of cobamide-dependent growth. Interestingly, although phenolyl cobamides bound SmMCM with high affinity and supported catalysis in vitro, high concentrations were required to support growth of S. meliloti. This discrepancy can be partially explained by poorer internalization or retention of these cofactors as compared to cobalamin ( Figure S5 ). The observation that the intracellular cobamide concentrations were 50-to 190-fold higher than the amount added to the growth medium ( Figure S5A ) suggests that cobamides could be internalized by an uptake mechanism that favors cobalamin, distinct from both BtuBFCD and ECF-CbrT Santos et al., 2018) , both of which are absent from S. meliloti. Thus, we propose a model in which the cobamide-dependent growth of bacteria is influenced not only by binding selectivity of cobamide-dependent enzymes, but also by cobamide import (Figure 6 ). The lower effectiveness of phenolyl cobamides in supporting growth of S. meliloti could additionally be explained by inefficient adenosylation of these cobamides in vivo, as MCM requires the adenosyl upper axial ligand for activity. Whether or not adenosyltransferase enzymes, specifically CobA and PduO (Escalante-Semerena et al., 1990; Johnson et al., 2001) in S. meliloti, are selective with respect to lower ligand structure is unknown.
We and others have proposed the possibility of manipulating microbial communities using cobamides by taking advantage of the differential cobamide-dependent growth of bacteria (Abreu and Taga, 2016; Degnan et al., 2014b; Seth and Taga, 2014; Yan et al., 2018) . Cobamides are predicted to mediate microbial interactions that are critical to the assembly of complex communities (Belzer et al., 2017; Degnan et al., 2014a; Heal et al., 2017; Helliwell et al., 2016; Ma et al., 2017; Men et al., 2015; Shelton et al., 2019; Yan et al., 2012) , so the ability to selectively inhibit or promote the growth of particular species using corrinoids with various lower ligands could be applied to alter the composition of microbial communities in ways that could promote environmental and human health. This possibility hinges on the ability to predict which cobamides support or inhibit growth of an organism of interest, which requires an understanding of the major biochemical determinants of growth. We observed here that the cobamide binding selectivity of a model base-off cobamide-dependent enzyme correlates with growth to a large extent. Thus, uncovering protein residues that confer selectivity would enable prediction of selectivity in cobamide-dependent enzymes, thereby facilitating prediction of the cobamide requirements of organisms of interest. Furthermore, our results suggest that additional steps of cobamide trafficking may be important determinants of cobamide-dependent growth. Future studies to understand how these various steps depend on cobamide structure will ultimately allow us to better understand, predict, and manipulate microbial interactions.
Materials and Methods

Chemical reagents
Chemicals were obtained from the following sources: 5'-chloro-5'-deoxyadenosine, Santa Cruz Biotechnology; 4-methylbenzimidazole, Accela; 5-methyl-1H-benzimidazole, ACROS Organics; phenol, J. T. Baker; zinc metal, Fisher Scientific; 5-methoxybenzimidazole, purine, and para-cresol, Alfa Aesar; methylmalonyl-CoA, methylmalonic acid, coenzyme A, adenosylcobalamin (coenzyme B 12 ), cyanocobalamin, dicyanocobinamide, 6-methylpurine, 1H-imidazo[4,5-c]pyridine-4-amine (3-deazaadenine), benzimidazole, adenine hemisulfate, 5-azabenzimidazole, 1H-benzo[d]imidazol-7-amine (4-aminobenzimidazole), 2-methyl-1H-purine-6-amine (2-methyladenine), and bovine serum albumin (BSA), Sigma.
Molecular cloning, protein expression and purification
SmMCM (locus SM_b20757, bhbA) was expressed from the pET28a vector, with an Nterminal hexahistidine (6xHis) tag, in E. coli BL21(DE3)pLysS (cloning primers listed in Table  S1 ). The expression strain was grown to an optical density at 600 nm (OD 600 ) of 0.6-0.8 at 37 ˚C, cooled on ice for 15 min, and induced with 1 mM IPTG for 2.5 h at 37 ˚C. Cells were lysed by sonication in 25 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, with 0.5 mM PMSF, 1 µg/mL leupeptin, 1 µg/mL pepstatin, and 1 mg/mL lysozyme. Clarified lysate was treated with 0.05% polyethyleneimine. An ÄKTA Pure 25 Fast Protein Liquid Chromatography (FPLC) system was used to purify the protein over a GE 5 mL HisTrap HF column, using a gradient of 21 to 230 mM imidazole in the lysis buffer. Purified protein was dialyzed into 25 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol and concentrated with a Vivaspin 10,000 MWCO protein concentrator. Final protein concentration was determined by A 280 using the theoretical extinction coefficient 55810 M -1 cm -1 (Fortier et al., 2012) . EcMCM (locus b2917, scpA, previously sbmA) was expressed with an N-terminal 6xHis tag from a pET28a vector in E. coli BL21(DE3), by induction at OD 600 0.6-0.8 with 0.1 mM IPTG, for 3.5 h at 30 ˚C. The protein was purified as described above and the final concentration was determined by Coomassie-stained SDS-PAGE, using BSA as a standard.
The V. parvula genome has two MCM annotations: a heterotetramer (loci Vpar_RS06295, Vpar_RS06290) and a heterodimer (loci Vpar_RS09005, Vpar_RS09000). The functionality of both homologs was tested by complementation in S. meliloti. The two putative VpMCM enzymes were cloned into the pTH1227 vector and transferred by conjugation into an S. meliloti bhbA::Tn5 mutant. Complementation was assessed by growth in M9 liquid medium containing L-isoleucine and L-valine (see "S. meliloti growth assays" for additional details). S. meliloti co-expressing Vpar_RS09005 and Vpar_RS09000 showed identical growth to a strain expressing SmMCM from pTH1227 and was selected for in vitro studies.
The α subunit of VpMCM (encoded by Vpar_RS09005) was expressed with an Nterminal 6xHis tag from the pET-Duet expression vector in E. coli BL21(DE3). Protein expression was induced with 520 µM IPTG for 6 h at 30 ˚C. The protein was batch purified by nickel affinity and subsequently purified by FPLC using a HiTrapQ column with an NaCl gradient from 50 to 500 mM in 20 Tris-HCl pH 8.0, 10% glycerol. The β subunit of VpMCM (encoded by Vpar_RS09000) was expressed separately with an N-terminal 6xHis tag from the pET-Duet expression vector in E. coli BL21(DE3). Expression was induced with 1 mM IPTG for 22 h at 16 ˚C and the protein was purified using nickel-affinity chromatography as described for SmMCM. Purified protein was dialyzed into 25 mM Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, and 1 mM β-mercaptoethanol. Concentration of α and β subunits was determined by absorbance at 280 nm (A 280 ) using the theoretically calculated extinction coefficients 75290 M -1 cm -1 and 74260 M -1 cm -1 , respectively (Fortier et al., 2012) . Equimolar amounts of α and β subunits were combined during the setup of fluorescence binding assays.
E. coli thiokinase containing an N-terminal 6xHis tag was expressed from a vector provided by Gregory Campanello from the laboratory of Ruma Banerjee. Expression was induced with 1 mM IPTG in E. coli BL21(DE3)pLysS at 28 ˚C for 3 h. The protein was purified as a heterodimer using nickel-affinity chromatography as described above. His-tagged Rhodopseudomonas palustris MatB (Crosby et al., 2012) was expressed from a pET16b expression plasmid provided by Omer Ad from the laboratory of Michelle Chang. The protein was overexpressed in E. coli BL21(DE3) at 16 ˚C overnight, after induction with 1 mM IPTG, and purified by nickel affinity chromatography as indicated above. Thiokinase and MatB concentrations were determined by Coomassie-stained SDS-PAGE, using BSA as a standard.
Guided biosynthesis, extraction, and purification of cobamides
Sporomusa ovata strain DSM 2662 was used for the production of its native cobamide, (Mok and Taga, 2013) . 5-OHBza was synthesized as described . Salmonella enterica serovar Typhimurium strain LT2 and Propionibacterium acidipropionici strain DSM 20273 were used for production of [Ade]Cba (Hoffmann et al., 2000; Yi et al., 2012) . Cobamides were extracted as previously described (Yi et al., 2012) and purified by High Performance Liquid Chromatography (HPLC) using previously published methods (Crofts et al., 2014; Crofts et al., 2013; Yi et al., 2012) as well as additional methods listed in Table S2 . In many cases more than one method was required to achieve high purity. Identity of cobamides was confirmed by Liquid Chromatography (LC) coupled to Mass Spectrometry (MS) using an Agilent 1260 LC/6120 quadrupole MS instrument. Lower ligand orientation in the novel cobamides 
Chemical adenosylation of cobamides
Cobamide adenosylation was performed as previously described (Brown and Zou, 1999; Crofts et al., 2014) . Briefly, cobamides at concentrations 0.5 -1 mM were reduced with activated zinc metal under anaerobic conditions, with vigorous stirring for 0.5 -2 h. 5'-chloro-5'-deoxyadenosine was added and adenosylation was allowed to proceed for 1 -3 h in the dark. The progress of the reaction was monitored by HPLC. Following adenosylation, cobamides were desalted using a C18 SepPak (Waters), purified by HPLC, desalted again, dried, and stored at -20 ˚C or -80 ˚C.
Cobamide quantification
Purified cobamides were dissolved in water and quantified by UV-Vis spectrophotometry on a BioTek Synergy 2 plate reader using the following extinction coefficients: for cyanylated benzimidazolyl cobamides, ɛ 518 = 7.4 x 10 3 M -1 cm -1 (Hogenkamp, 1975) ; for cyanylated purinyl cobamides, ɛ 548 = 7.94 x 10 3 M -1 cm -1 (Schneider and Stroinski, 1987) ; for cyanylated phenolyl cobamides, ɛ 495 = 9.523 x 10 3 M -1 cm -1 (Stupperich et al., 1988) (Schneider and Stroinski, 1987) ; for adenosylated azabenzimidazolyl cobamides (Ado[3-DeazaAde]Cba, Ado[5-AzaBza]Cba and Ado[6-MePur]Cba), which are a mixture of base-on and base-off in water, the concentration was estimated from the average of concentrations calculated using the extinction coefficients above.
Fluorescence Binding Assays
An in vitro assay previously described for measuring binding of AdoCbl to P. shermanii MCM (Chowdhury and Banerjee, 1999 ) was adapted to a 96-well format: MCM (0.2 µM) was combined with a range of cobamide concentrations (as specified in each experiment) in a black 96-well plate in 50 mM potassium phosphate pH 7.5 with 1 mM DTT, on ice. All steps involving cobamides were conducted in the dark. The plate was centrifuged for 1 min at 3800 rpm to level the surface of the liquid in each well. The plate was then incubated for 40 min at 30 ˚C to allow binding, with a brief shaking step after 30 min. Preliminary experiments showed that this time is sufficient for equilibration. Following incubation, fluorescence emission at 340 nm (5 nm slit width) was measured upon excitation at 282 nm (5 nm slit width) using a Tecan Infinite M1000 PRO Plate Reader. Fluorescence, normalized to the initial value, was plotted as a function of cobamide concentration, and fit to the following equation (Warner and Copley, 2007) :
where F is fluorescence, F 0 is initial fluorescence, [E] is total enzyme concentration, [L] is total ligand concentration, and K d is the binding dissociation constant.
Filtration binding assay
Cobamides (10 µM) with and without MCM (15 µM) were incubated in 50 mM Trisphosphate buffer pH 7.5 at 30 ˚C for 40 min, transferred to Nanosep 10K Omega centrifugal devices (Pall Corporation), and centrifuged for 5 minutes at 13,900 x g to separate unbound cobamides from enzyme-bound cobamides. The UV-Vis spectra of the filtrates were recorded on a BioTek Synergy 2 plate reader.
Structural modeling
A model of SmMCM was generated using the Swiss-Model software (Guex et al., 2009 ) based on the known crystal structure of Homo sapiens MCM (HsMCM) (PBD ID: 2XIJ) (Froese et al., 2010) . No major differences were observed in the B 12 -binding domain between SmMCM models generated from HsMCM and Propionibacterium freudenrichii MCM (PDB ID: 4REQ) (Mancia et al., 1996) .
Maestro(Schrödinger Release 2015: Maestro) was used to generate a model of HsMCM bound to [Ade]Cba. The initial structure of HsMCM bound to cobalamin (PDB ID: 2XIQ) (Froese et al., 2010) was prepared using standard methods. A constrained energy minimization (atoms within 10 Å of cobalamin freely moving; atoms within a second 10 Å shell constrained by a force constant of 200; remaining structure frozen) was performed using MacroModel (Schrödinger Release 2015: MacroModel) . The structure of the lower ligand was then modified to adenine, and the constrained energy minimization was repeated to generate a model of the lower ligand binding pocket bound to [Ade]Cba.
Enzymatic synthesis of (R)-methylmalonyl-CoA (R)-methylmalonyl-CoA synthesis reactions contained the following in 10 mL: 100 mM sodium phosphate pH 7.5, 20 mM MgCl 2 , 5 mM ATP, 10 mM methylmalonic acid, 2 mM coenzyme A, 5 mM β-mercaptoethanol, and 1.5 µM purified MatB protein. After combining ingredients on ice, the reaction was incubated at 37 ˚C for 1 h. The reaction was then frozen in liquid nitrogen and lyophilized. To purify (R)-methylmalonyl-CoA, the dried reaction mixture was resuspended in 3.2 mL water and the protein was precipitated with 200 µL trichloroacetic acid; precipitate was pelleted; supernatant was neutralized with 200 µL of 10 M NaOH; and salts and remaining starting materials were removed using a C18 SepPak column (Waters) (loaded in 0.1% formic acid, washed with water, methylmalonyl-CoA eluted with 50% methanol in water). Formation of (R)-methylmalonyl-CoA was initially verified by 1 H NMR and in subsequent preparations by HPLC (Table S3 ). The concentration of (R)-methylmalonyl-CoA was determined using an extinction coefficient of 12.2 mM -1 cm -1 at 259 nm.
MCM activity assays
A thiokinase-coupled, spectrophotometric MCM activity assay was adapted from previous work (Taoka et al., 1994) , except that ADP was used instead of GDP, and the experiment was conducted in 96-well plates. Final concentrations of reagents in the assays are as follows: Tris-phosphate buffer pH 7.5, 50 mM; DTNB, 400 µM; ADP, 1 mM; MgCl 2 , 10 mM; (R)-methylmalonyl-CoA, 0 -4 mM; thiokinase, 5 µM; MCM, 50 nM; and cobamides, 2 µM. Preliminary experiments were conducted to ensure that concentrations of thiokinase, DTNB, and cobamides were not rate limiting.
Three separate mixes were prepared, all in 1X Tris-phosphate buffer: an assay mix containing DTNB, ADP, and MgCl 2 , a substrate mix containing (R)-methylmalonyl-CoA, and an enzyme mix containing thiokinase, MCM, and cobamides. All steps involving cobamides were conducted in the dark. The assay and enzyme mixes were prepared as a master mix and aliquoted into 96-well plates; substrate mixes were prepared in individual wells, in triplicate. All components were incubated at 30 ˚C for 40 minutes to equilibrate temperature and allow prebinding of cobamides and MCM. After incubation, one replicate at a time, the substrate mix was added to the assay mix, followed by the enzyme mix. Absorbance at 412 nm (A 412 ) was recorded immediately after addition of enzyme and for 1-3 minutes, every 3 seconds, on a BioTek Synergy 2 plate reader. The increase in A 412 in reactions lacking substrate was subtracted from all readings, to account for reactivity of DTNB with thiols on protein surfaces. A 412 values were converted to concentration of free CoA using a pathlength correction determined for the reaction volume and extinction coefficient of 14150 M -1 cm -1 .
S. meliloti growth assays
MCM-dependent growth experiments were performed with S. meliloti strain Rm1021 cobD::gus Gm R metH::Tn5 ∆nrdJ pMS03-nrdAB Ec + , which lacks cobamide-dependent enzymes other than MCM and does not synthesize cobalamin. cobD is required for cobalamin biosynthesis (Campbell et al., 2006) , metH encodes methionine synthase (Banerjee et al., 1989; Campbell et al., 2006; Sato et al., 1974) , and nrdJ encodes ribonucleotide reductase (Cowles et al., 1969) . Because nrdJ is essential, the E. coli cobamide-independent ribonucleotide reductase encoded by nrdA and nrdB was expressed from the pMS03 plasmid (Taga and Walker, 2010) . The strain was pre-cultured in M9 medium (Maniatis et al., 1989 ) (modified concentration of MgSO 4 : 1 mM) containing 0.1% sucrose, 2 g/L isoleucine, 2 g/L valine, 1 g/L methionine, and 20 µg/mL gentamycin, shaking at 30 ˚C. After two days, cells were washed and diluted to an OD 600 of 0.02 into M9 medium containing 4 g/L isoleucine, 4 g/L valine, 1 g/L methionine, 20 µg/mL gentamycin, and cobamides at various concentrations as indicated for each experiment, in 384-well plates. The plates were incubated at 30 ˚C for 145 h in a Biotek Synergy 2 plate reader with linear shaking at 1140 cpm. OD 600 was measured in 1 h increments.
For quantification of intracellular cobamides in S. meliloti, the strain above was precultured as described, diluted into 50 mL of M9 medium containing 0.2% sucrose and various cobamides, and grown for 48 h (until OD 600 0.6-0.8). Cobamides were extracted from cell pellets as previously described (Yi et al., 2012) , using 5 mL of methanol containing 500 µg of potassium cyanide, and including a partial purification by means of a wash step with 20% methanol in water during the SepPak desalting procedure. Extracted cobamides were quantified by HPLC using peak areas at 525 nm and external standard curves, and cellular cobamide concentrations were calculated assuming 8 x 10 8 cells/mL at OD 600 1.0 and cellular volume of 1 µm 3 . Figure 1: The structure of cobalamin. The lower ligand, boxed, varies in other cobamides. Cobinamide, a cobamide precursor, lacks a nucleotide base (delineated by the wavy line). Figure 2: Binding of diverse cobamides to SmMCM (see also Figures S1, S2 ). Fluorescence decrease of SmMCM when reconstituted with (A) benzimidazolyl cobamides and cobinamide, (B) phenolyl and purinyl cobamides, and (C) additional cobamide analogs (benzimidazolyl cobamides, blue; purinyl cobamides, orange; azabenzimidazolyl cobamides, black). Data points represent the mean and standard deviation of three technical replicates from a single experiment. (D) Kd values for different cobamides, reported as the average and standard deviation of three or more independent experiments, each consisting of technical triplicates. "n. d.," not determined, indicates that binding was too weak to determine Kd. *While it was unreported at the time of our study, [Pur] Cba was discovered to be the cobamide naturally produced by Desulfitobacterium hafniense (Yan et al., 2018) . (A) Succinyl-CoA formation was detected using a coupled spectrophotometric assay (Taoka et al., 1994) . DTNB, dithionitrobenzoate (Ellman's Reagent); TNB, thionitrobenzoate; CoA, Coenzyme A. (B) Michaelis-Menten kinetic analysis of SmMCM reconstituted with various cobamides. Data points and error bars represent the mean and standard deviation, respectively, of three technical replicates from one experiment; each replicate consisted of an independent substrate dilution. Kinetic constants are presented in (C). Cobamides differentially impact bacterial growth due to selective cobamide import and biosynthesis, cobamide-binding selectivity of cobamide-dependent enzymes, and cobamide-dependent catalysis. For MCM-dependent growth of S. meliloti, cobamide-binding selectivity is most strongly correlated with cobamide-dependent growth of the organism.
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